Introduction {#s1}
============

Unnecessary and excessive use of antibiotics is the main driver of antimicrobial resistance.[@R1] The prospect of patients dying from common infections caused by multiresistant bacteria in the long term is grim unless the situation is reversed by limiting the use of antibiotics only to patients in whom the benefits outweigh the harms.

Since the publication of the book 'Overdiagnosed: Making People Sick in the Pursuit of Health' by Welch *et al* in 2011[@R2] and the launching of the first International conference on overdiagnosis in 2013, overdiagnosis has become a widely used term to address the drivers of 'too much medicine'.

Well-defined concepts are essential to advance understanding and to find concrete solutions to a problem. In that sense, Brodersen *et al* published a paper about what is and is not overdiagnosis.[@R3] In this paper, overdiagnosis is defined as the diagnosis of a condition, that would otherwise not cause symptoms or harm to a patient during his or her lifetime'. They go further by arguing that terms such as *overtesting, misdiagnosis and false-positives* do not belong to the overdiagnosis paradigm.

This assertion has raised more questions than answers within the clinical and research area regarding infectious diseases and the use of antibiotics. In this paper, we summarise the main points discussed during the workshop 'Overdiagnosis and overtreatment of infectious diseases in general practice. How and where to break the endless loop?'.[@R4] During the workshop, participants from all over the world reflected on the challenges of embracing the overdiagnosis paradigm as a tool to advance understanding and to find solutions to the unnecessary use of antibiotics in primary healthcare.

It was concluded that the current definition of overdiagnosis is not suitable and falls short of addressing the complexity of the drivers and consequences of excessive and unnecessary use of antibiotics. On the contrary, the 'too much medicine' paradigm[@R5] gives space for a broader understanding of overdiagnosis as errors during the diagnostic process, which are inherently connected to the error in the treatment decision called overtreatment.

Overdiagnosis versus 'too much medicine' {#s2}
========================================

The current definition of overdiagnosis is based on long-term or chronic conditions and asymptomatic patients. It markedly differs from the type of population managed in primary healthcare due to a suspected acute infectious disease.

First of all, all the patients seeking care at primary healthcare have atypical or typical symptoms, a type of perceived change that triggers the need for seeking healthcare. Second, the focus of benefits against harms is mostly driven by outweighing the benefit of shortening the length of time with symptoms against the harms due to the development of adverse effects including the development of antimicrobial resistance.[@R6]

Therefore, neither the overdiagnosis of an asymptomatic patient nor the development of unforeseen long-term harms is the main problem regarding the diagnosis and subsequent management of patients with a suspected acute infection.

The main problem is the interplay of multilevel factors that influence the diagnostic process and treatment decision, which leads to overtreatment.[@R8] From this perspective, the 'too much medicine' paradigm is an umbrella term that gives room for recognising the singularities of each error while reminding us that they are part of a bigger picture.

Looking for solutions to the unnecessary use of antibiotics is far from being an easy task. Determinants and actions targeting diagnostic errors influence the treatment decision and vice versa. Understanding the components of the bigger picture and the challenges of the diagnostic errors within the 'too much medicine' paradigm are crucial to bringing about effective solutions.

The bigger picture {#s2a}
------------------

Worldwide, the patient--doctor encounter in primary care faces similar challenges such as (a) short consultation time, (b) high uncertainty of the origin of the symptoms, (c) uncertainty of the evolution of symptoms and (d) organisational challenges for following the patient.[@R9]

During the patient--doctor encounter, patients' expectations and general practitioners' (GP) attitudes toward these expectations are drivers of 'too much medicine'. As mentioned above, there are typical and atypical symptoms that trigger an active search for healthcare. Patients/the family expect something from their GP. It can include a check-up, reassurance, a medical certificate, antibiotic therapy or simply guidance on symptom management.

GPs who perceive high patient expectations for antibiotics are more likely to prescribe antibiotics (ie, overtreatment) unnecessarily. A recent study in Australia found that more than half of the GPs included in the study self-reported that they would prescribe antibiotics for an upper respiratory tract infection to meet patient expectations.[@R11] However, while all patients are believed to expect something, only some patients expect antibiotics, and among these patients, a subset demands antibiotics. Notwithstanding, patient expectations may be based on false assumptions, with many overestimating the effectiveness of antibiotic treatment.[@R12]

It is very important for GPs to meet patients' expectations, as it is a way to preserve a good doctor--patient relationship. Prescribing increases patient satisfaction and reinforces the doctor--patient relationship as clinicians often feel prescribing as less stressful than an anxious patient or parent.[@R13] Some clinicians do not feel that it is worth jeopardising their relationship with a patient or parent over a relatively minor matter of prescribing antibiotics. The consequences for the future relationship with patients are more of a concern for GPs prescribing antibiotics than antibiotic resistance.[@R9] GPs are generally aware of and concerned about the threat that antimicrobial resistance poses and agree that this is a growing problem. However, antimicrobial resistance is considered more of a public health issue, whereas the GPs' priority is to be responsive to the needs of the individual patient.

This example shows the multidimensional factors that play a role in the decision whether to prescribe antibiotics. There is a patient expecting a solution to his/her problems. There is a GP expecting to be responsive to the needs of the patient. There is a system expecting a rational use of resources and contention of the antimicrobial resistance problem.

The challenges of the diagnostic errors {#s2b}
---------------------------------------

*Mislabelling or misdefinition*,[@R14] not considered as overdiagnosis under the definition of overdiagnosis of Brodersen *et al*, is an error during the diagnostic process. However, it is difficult to know whether mislabelling lead to overtreatment or vice versa. Due to the short time of the consultation in primary care, it is difficult to determine the logical order of the decision taken by the GP. Sometimes a GP mislabels the patient with another diagnosis to better justify the administration of antibiotic therapy, for which treatment is unnecessary. A clear example is the differentiation of a sore throat into two different labels (pharyngitis and tonsillitis). Patients are diagnosed with tonsillitis if the clinicians intend to treat a sore throat with antibiotics and they use the milder category of pharyngitis if they think that the infection has a viral cause. In extreme cases, GPs decide to prescribe antibiotics even before examining the patient.[@R15] It goes against logical thinking as treatment should be the subsequent step after a systematic diagnostic process.

It implies that the current system to assess overtreatment is quite inaccurate. Future research should focus on finding better ways to assess overtreatment and the extent of mislabelling. For example, the assessment should be based on the presence of diagnostic information (eg, cluster of signs and symptoms, results of rapid tests) as well as prognostic criteria (eg, age and comorbidities) rather than the label given by the prescriber.

Other examples of the broader vision of errors in the diagnostic process connected to the decision to treat are *overtesting* and *misinterpretation* of diagnostic information (ie, false positives). These terms are not considered as overdiagnosis under the Brodersen *et al* definition of overdiagnosis.

Currently, there is no single item of the diagnostic information (eg, signs, symptoms and results of rapid tests) able to predict whether an infection has a viral or a bacterial origin with 100% certainty. Systematic reviews about the diagnostic accuracy of signs and symptoms for the most common infections managed in primary care[@R16] have shown that the specificity of signs and symptoms is low. The cluster of symptoms like *the Centor criteria---*used to predict the bacterial origin of a sore throat[@R18]---or the cluster of symptoms to identify patients with influenza-like symptoms,[@R19] who can benefit from early antiretroviral therapy can increase predictive accuracy, but it depends on the prevalence of the disease.[@R20] Thus, a treatment decision only based on signs and symptoms is likely to yield a high proportion of false-positives, resulting in overtreatment.

The use of rapid tests has been advocated as a solution to increase diagnostic accuracy, thereby decreasing overtreatment.[@R21] However, the introduction of this technology in primary care is in its infancy with a lot of controversy about the added value.[@R22]

Models to understand the factors influencing the proper use and added value of rapid testing in primary care have demonstrated a complex interaction between availability, interpretation and easy-to-use factors.[@R24]

Currently, rapid tests to support the diagnostic process in patients with a suspected infection seeking help in primary care are available in very few countries. In most of the world, the decision of whether to prescribe antibiotics is taken based only on signs and symptoms.

One of the few countries with the wide availability of rapid tests is Denmark. This scenario allowed us to assess the use of diagnostic tools in daily practice and its effect on treatment decision in patients with suspected urinary tract infection (UTI).[@R25] We found that in 85% of the patients with a suspected uncomplicated UTI, urine culture was part of the diagnostic process. Many international guidelines recommend the use of urine culture only in patients with suspected complicated UTI; then this 85% could be regarded as *overtesting*. However, overtreatment was lower in the group of patients in which urine culture was performed in comparison with the group of patients in which antibiotics were prescribed based only on signs and symptoms. To disentangle the causal path between the use of rapid test and overtreatment is not straightforward. Thus, there is a growing awareness about the fact that the assessment of the causal pathway between the use of a rapid test and the effect on overtreatment needs re-structuring. The field of diagnostic test evaluation requires further development and operationalisation of variables within the 'too much medicine' paradigm if the rapid tests are to become systematically introduce in primary healthcare worldwide.

Conclusion {#s3}
==========

Overall, it can be seen that the overdiagnosis paradigm is unrelated to these multidimensional factors. The type of population, as well as the dilemmas regarding benefits and harms in the management of patients with suspected infections, differ in crucial aspects of the population and dilemmas covered by the overdiagnosis paradigm. The umbrella term of too much medicine is broader and allows the use of theories and strategies without getting trapped into the dilemmas of trying to squeeze the multidimensional factors of diagnostic error and overtreatment into the narrow definition of what is and is not overdiagnosis.
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